Clinical Trial Update: FACTO Study (Foster® As Complete Treatment Option) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for Foster (budesonide/formoterol) in asthma, noting the FACTO study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Foster (budesonide/formoterol)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthmatic Patients | Phase 4 | Status: COMPLETED